The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
By 2030, How Much Growth In Market Size Is Expected For The Breast Cancer Screening Test Market?
The market size for breast cancer screening tests has demonstrated strong expansion in recent years. It is forecast to rise from $2.49 billion in 2025 to $2.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. This growth during the historical period can be attributed to a combination of factors, including increasing awareness regarding breast cancer incidence, the broad implementation of mammography screening programs, an expanding diagnostic laboratory infrastructure, the establishment of standardized screening guidelines, and a rise in public health screening initiatives.
The breast cancer screening test market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $3.68 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. The anticipated growth during this period stems from several factors, including the increasing implementation of personalized cancer screening protocols, the expanding utilization of AI-powered diagnostic tools, the wider acceptance of genetic testing, a heightened emphasis on detecting cancer in its early stages, and greater investments in preventive oncology services. Key trends observed within the forecast timeframe encompass the growing uptake of advanced imaging-based screening methods, the increasing application of genetic and molecular diagnostics, the expanding incorporation of AI in image analysis, the proliferation of multi-modal screening strategies, and an intensified focus on early and preventative diagnostic measures.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24180&type=smp
What Influential Factors Are Boosting The Breast Cancer Screening Test Market Demand?
The increasing incidence of breast cancer is projected to stimulate the expansion of the breast cancer screening test market in the coming years. Breast cancer is characterized by the unchecked proliferation of abnormal cells within breast tissue, which can form a tumor and potentially spread to other regions of the body. The escalation in breast cancer cases is attributed to the global aging population, given that advanced age is a primary risk factor for the condition, and longer life expectancies mean more individuals are susceptible. Breast cancer screening tests aid in the early detection of the disease, thereby improving the chances of successful treatment and decreasing mortality linked to breast cancer. For instance, in March 2025, Breastcancer.org, a US-based nonprofit organization, reported an expectation of around 316,950 women receiving a diagnosis of invasive breast cancer in 2025, while 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS) are anticipated. Consequently, the rising breast cancer incidence rates are a key driver for the growth of the breast cancer screening test market.
Which Segment-Based Categories Are Covered In The Breast Cancer Screening Test Market?
The breast cancer screening test market covered in this report is segmented –
1) By Diagnostic Test Type: Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test
2) By Risk Level: High-risk Population, Moderate-risk Population, Average-risk Population
3) By End User: Hospitals, Diagnostic Centres, Cancer Institutes, Research Laboratories
Subsegments:
1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test, Gene Expression Profiling Test, Circulating Tumor Dna (Ctdna) Test, Proteomic Biomarker Test
2) By Imaging Test: Mammography, Magnetic Resonance Imaging Screening Test, Molecular Breast Imaging Test, Positron Emission Mammography, Ultrasound
3) By Genetic Test: Fluorescence In Situ Hybridization, Her Gene Test
4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test, Ki-67 Proliferation Marker Test, Progesterone Receptor (Pr) Test, Her2 Or Neu Test
Which Trends Are Affecting The Breast Cancer Screening Test Market Framework?
Key companies in the breast cancer screening test market are prioritizing the development of innovative products, such as mobile cancer screening units, to improve accessibility, increase early detection rates, and expand screening coverage in remote and underserved areas. A mobile cancer screening unit is a transportable facility equipped with diagnostic imaging technologies like mammography, designed to offer on-site breast cancer screening services in hard-to-reach locations. For example, in September 2024, Granules India Ltd., an India-based pharmaceutical company, launched a Breast Health Express to enhance breast cancer screening within underprivileged communities. This unit incorporates state-of-the-art mammography and ultrasound technology, enabling high-quality screenings on the go. The initiative aims to reach underserved and rural communities where healthcare access is often limited, ensuring women in distant areas can access vital early detection services.
Who Are The Firms Contributing To The Breast Cancer Screening Test Market Ecosystem?
Major companies operating in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD (Becton Dickinson and Company), Agilent Technologies Inc.
Access The Complete Breast Cancer Screening Test Market Report:
https://www.thebusinessresearchcompany.com/report/breast-cancer-screening-test-global-market-report
Which Regional Market Leads The Breast Cancer Screening Test Market?
North America was the largest region in the breast cancer screening test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer screening test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Breast Cancer Screening Test Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=24180&type=smp
Browse Through More Reports Similar to the Global Breast Cancer Screening Test Market 2026, By The Business Research Company
Cellular Health Screening Market Report 2026
https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report
Next Generation Gynecological Cancer Diagnostics Market Report 2026
Breast Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model